RT @EyeVidence: #GeneTherapy for eye diseases are commonly AAV based and deliver…


RT @EyeVidence: #GeneTherapy for eye diseases are commonly AAV based and delivered subretinal, which is associated with some risk. This stu…


Source by Thomas Ciulla, MD, MBA

Return to main website.